Oxford Biodynamics PLC
OXFORD, X0 · CIK 0001892722 · Medtech · Public
EpiSwitch diagnostic platform that measures epigenetic biomarkers from blood samples
oxfordbiodynamics.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $5.0M
- 1 Form D · Nov 2021
- 59 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 24
- 11 granted · 13 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20212022
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $5,000,000 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1446 | Clear Advantage Collar, Inc. | — | $360K |
| 1447 | Obstetrx, Inc. | — | $1.1M |
| 1448 | Anuncia Medical, Inc. | — | $12M |
| 1449 | Oxford Biodynamics PLC | — | $5.0M |
| 1450 | EUTROPICS PHARMACEUTICALS, INC. | — | $350K |
| 1451 | CELLOGY, INC. | — | — |
| 1452 | SOSTOS LLC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Alexandre AkoulitchevDirector
- Jon BurrowsDirector · Executive Officer
- Stephen DiggleDirector
- David HolbrookDirector
- Paul StockdaleDirector · Executive Officer
- Matthew WakefieldDirector
Patents
- Chromosome Conformation Markers of Autism Spectrum Disordergranted
- Chromosome Biomarkergranted
- Chromosome Interactionsapplication
- Detection Of Chromosome Interactions As Indicative Of Amyotrophic Lateral Sclerosisgranted
- Chromosome Interaction Markersapplication
- Disease Markerapplication
- Genetic Regulation Of Immunoresponse By Chromosome Interactionsgranted
- Detection Processes Using Sites Of Chromosome Interactiongranted
- Epigenetic Chromosome Interactionsgranted
- Detection Of Chromosome Interaction Relevant To Breast Cancergranted
- Detecting A Chromosome Confirmation As Marker For Fibrosis, E.g. Slerodermaapplication
- Application Of Epigenetic Chromosomal Interactions In Cancer Diagnosticsapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.